Creating a shortcut to better health by improving patient compliance
Bang & Olufsen Medicom, a wholly owned subsidiary of the Bang & Olufsen group, is a leading expert in the design, development and supply of innovative drug delivery device solutions and sensor based technologies. The current product range includes; inhalers, tablet reminders and injection pens with a focus on patient compliance.
Bang & Olufsen Medicom offers concept development, engineering and manufacturing services to clients with options to license its intellectual property.
Bang & Olufsen Medicom focuses on patient compliance, as the average patient forgets every second dose (patients on average have a 50% compliance rate – WHO Report 2003). Therefore we believe that patients need help to remember to take their medication and a motivation to keep on track to continue their full course of prescribed medication.
For more information you can visit: